Salvianolic Acid C - An Overview
trastuzumab deruxtecan, pazopanib. Both boosts toxicity of one other by immunosuppressive outcomes; risk of infection. Use Caution/Keep track of. Neutropenia or febrile neutropenia incidence have been improved when trastuzumab was coadministered with myelosuppressive chemotherapy. .Otesezonale, a BCRP inhibitor, could raise the results and danger o